The Braves’ financial release on Wednesday didn’t exactly read like a victory lap on the business side, even if the on-field season gave them plenty to smile about.
The club pointed to BravesVision and the 2026 City Connect jerseys as clear wins, but the more interesting line came from Terry McGuirk, who framed the year as a step forward and said the team had made a choice to spend.
“I want to be clear about how I see this season. It was real progress.
We went from missing the playoffs to winnings the division and a postseason series. Our core is in place.
Our young players go better and our new manager’s first year was a success. Our minor league system is stocked with future major league talent.
We’re pleased with where this organization is headed and will keep working to build on it in 2027. … Coming into this season, we made a deliberate decision to invest in our roster and our major league payroll was meaningfully higher as a result.”
That’s the claim. The numbers that followed made it a lot harder to sell.
The money that disappeared in 2025 was substantial: Marcell Ozuna at minus $16 million, Jurickson Profar at minus $7.5 million after playing half the year in 2025 and zero games in 2026, and Pierce Johnson at minus $7 million.
On the other side, the Braves brought in Ha-Seong Kim at $20 million, Robert Suarez at $13 million, Mike Yastremski at $9 million, Joel Payamps at $2.5 million, and Mauricio Dubon at roughly $5 million through a trade. They also absorbed bigger numbers from existing players, with Spencer Strider adding $16 million more, Reynaldo Lopez adding $6 million more, and Aaron Bummer adding $5.5 million more.
All told, the Braves added $77 million. But $27.5 million of that came simply from contracts increasing in value, not from fresh spending. However it got there, the club ended up with eight meaningful contracts added and three removed.
The production didn’t match the payroll bump. The Braves’ $77 million in additions produced just 2.4 WAR, and that was all Dubon.
The other seven players returned 0.0 WAR. The players who left in 2025 and didn’t come back were worth 2.9 WAR.
So even with a better season on the field, the financial case is murky at best. The Braves were better this year, but the added money wasn’t the reason. If anything, the release strengthened the argument against spending just to spend.
In Other News...
Braves Fans Have A New Homegrown Bat Worth Watching
Conor Essenburg has quickly become one of the more intriguing names in the Braves system, the kind of homegrown bat that can make a farm report feel a little more relevant to the big-league picture. The 2025 fifth-round pick got off to an injury-shortened start in pro ball, but the early signs of progress have been encouraging, with better hitting, improved plate discipline and more power showing up as he moved through the minors.
A promotion to Rome followed, and that is usually where a prospect starts to separate himself from the pack or fade into the background. Essenburg has done enough to keep drawing attention, and the industry buzz around him suggests there could be something bigger coming if the development keeps trending the right way. For Braves fans looking beyond the current roster, he is the sort of outfielder worth tracking closely as the system searches for the next real breakout. [Read more 🡒]
Braves Would Have To Ignore One Real Concern To Sign Shota Imanaga
Shota Imanaga has built a strong case over three major league seasons, giving teams a steady left-handed starter with a 3.45 ERA and 6.5 bWAR across 86 starts. Even so, the market around him has stayed a little cooler than you might expect for a pitcher with that kind of track record, with early projections landing around a two-year, $40 million deal.
For the Braves, the appeal is obvious enough. Imanaga has been productive and consistent, but the concern is just as clear: his fly-ball profile can make him a tricky fit for clubs that do not want to live with extra damage on mistakes. Teams with more forgiving ballparks may be more willing to look past that, which is why Atlanta would have to decide whether the upside is worth accepting a real risk that has followed him throughout his time in the majors. [Read more 🡒]
Chris Sale Is Giving The Braves Historic Greatness And One Huge Worry
Chris Sale has given Atlanta exactly the kind of ace-level certainty teams spend years chasing. Since arriving with the Braves, he has been an All-Star every season, won the National League Cy Young Award in 2024 and kept producing at a level that puts him in rare company for pitchers in their mid-30s. The mix has been familiar but still impressive: plenty of strikeouts, better velocity and the kind of dominance that has made him one of the most valuable arms in the sport.
The concern, of course, is the same one that has followed Sale for much of his career. Even with the historic run he has put together in Atlanta, his injury history remains part of the conversation every time he takes the mound, and that reality hangs over a Braves rotation that has learned how much it can change when he is healthy. For now, the payoff has been obvious, but the long view still comes with one unavoidable question. [Read more 🡒]